Specifically, the ChP volume shows significant correlations with the p-tau and t-tau levels in each patient group, while it is not significantly correlated with the Aβ42 and Aβ40 in the CN, MCI, and AD groups. This evidence concerns the gene MAPT and Alzheimer disease.